Belluscura has reported interims in line with our expectations and notes strong momentum across its product range, particularly the DISCOV-R, and ‘transformational' progress in its global roll-out after signing Agreements with InnoMax and McKessen.


Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Interim results
Belluscura PLC (BELL:LON) | 20.0 0 0.0% | Mkt Cap: 27.5m
- Published:
13 Sep 2023 -
Author:
Paul David Richards | Lorne P. Daniel -
Pages:
9 -
Belluscura has reported interims in line with our expectations and notes strong momentum across its product range, particularly the DISCOV-R, and ‘transformational' progress in its global roll-out after signing Agreements with InnoMax and McKessen.